Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad

Indian Journal of Medical Research

Volumn 134, Issue 11, 2011, Pages 704-708

  Thati, Venubabu ^a   Shivannavar, Channappa T ^a   Gaddad, Subhaschandra M ^a  

^a GULBARGA UNIVERSITY   (India)

Author keywords

MRSA; Staphylococcus aureus; vanA gene; Vancomycin; VRSA

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; INDIA; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POLYMERASE CHAIN REACTION; TERTIARY HEALTH CARE; VANA GENE;

ANTI-INFECTIVE AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INDIA; INTENSIVE CARE UNITS; METHICILLIN; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 82155164380     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Van Belkum A, Verbrugh H. 40 years of methicillin-resistant Staphylococcus aureus. MRSA is here to stay - but it can be controlled. BMJ 2001; 323: 644-5.
2. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolution, epidemiologic and therapeutic Odyssey. Clin Infect Dis 2005; 40: 562-73.
3. Maranan MC, Moreira B, Boyle-Vavra S, Daum RS. Antimicrobial resistance in Staphylococci. Epidemiology, molecular mechanisms, and clinical relevance. Infect Dis Clin North Am 1997; 11: 813-49.
4. Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, Mac-Gowan AP. A modifed population analysis (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 2001; 47: 399-403.
5. Hiramatsu K, Hanaki H, Ino T, Oguri YT, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced susceptibility. J Antimicrob Chemother 1997; 40: 135-6.
6. Cui L, Iwamoto A, Lian JQ, Neoh HM, Maruyama T, Horikawa Y, et al. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50: 428-38.
7. Bozdogan BÜ, Esel, D, Whitener C, Browne FA, Appelbaum PC. Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center. J Antimicro Chemother 2003; 52: 864-8.
8. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993; 175: 117-27.
9. Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. Infect Dis 2006; 6: 156.
10. Oliveira GA, Dell'Aquila AM, Masiero RL, Levy CE, Gomes MS, Cui L, et al. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect Control Hosp Epidemiol 2001; 22: 443-8.
11. Poly MC, Grelaud C, Martin C, de Lumley L, Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998; 351: 1212.
12. Howe RA, Bowker KE, Walsh TR, Feest TG, Mac-Gowan AP. Vancomycin-resistant Staphylococcus aureus. Lancet 1998; 351: 602.
13. Bierbaum G, Fuchs K, Lenz W, Szekat C, Sahl HG. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 691-6.
14. Assadullah S, Kakru DK, Thoker MA, Bhat FA, Hussain N, Shah A. Emergence of low level vancomycin resistance in MRSA. Indian J Med Microbiol 2003; 21: 196-8.
15. Pierard D, Vandenbussche H, Verschraegen I, Lauwers S. Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in a Belgian hospital. Pathologie Biologie 2004; 52: 486-8.
16. th informational supplement (M100-517). Wayne, Pa: Clinical and Laboratory Standards Institute; 2007.
17. Biswajit S, Anil KS, Abhrajyoti G, Manjusri B. Identifcation and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol 2008; 57: 72-9.
18. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM. Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 2003; 21: 49-51.
19. Benjamin PH, John KD, Paul DR. J, Timothy PS, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin- intermediate strains: Resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 2010; 23: 99-139.
20. Menezes GA, Harish BN, Sujatha S, Vinothini K, Parija SC. Emergence of vancomycin-intermediate Staphylococcus species in southern India. J Med Microbiol 2008; 57: 911-2.
21. Bhateja P, Mathur T, Pandya M, Fatma T, Rattan. A Detection of vancomycin resistance Staphylococcus.aureus: A comparative study of three different phenotyic screening mehods. Indian J Med Microbiol 2005; 23: 52-5.
22. Bijiyani B, Purva M. Erroneous reporting vancomycine susceptibility for Staphylococcus spp. Vitek software version 2.01. Jpn J Infect Dis 2009; 62: 298-9.
23. Veer P, Chande C, Chavan S, Wabale V, Chopdekar K, Bade J, et al. Increasing levels of minimum inhibitory concentration vancomycin in methicillin resistant Staphylococcus aureus alarming bell for vancomycin abusers?. Indian J Med Microbiol 2010; 28: 413-4.
24. De Lassence A, Hidri N, Timsit JF, Joly-Guillou ML, Thiery G, Boyer A, et al. Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2006; 42: 170-8.
25. Schweiger ES, Scheinfeld NS, Tischler HR, Weinberg JM. Linezolid and quinupristin/dalfopristin: novel antibiotics for Gram-positive infections of the skin. J Drugs Dermatol 2003; 2: 378-83.
26. Jansen A, Turck M, Szekat C, Nagel M, Clever I, Bierbaum G. Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus. Int J Med Microbiol 2007; 297: 205-15.
27. Kuroda M, Kuwahara-Arai K, Hiramatsu K. Identifcation of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. Biochem Biophys Res Commun 2000; 269: 485-90.
28. Maki H, McCallum N, Bischoff M, Wada A, Berger-Bachi B. tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2004; 48: 1953-9.
29. Noble WC, Virani Z, Cree RGA. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195-8.